×

Evotec AG Share Holder Equity 2010-2024 | EVO

Evotec AG share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Evotec AG Annual Share Holder Equity
(Millions of US $)
2023 $1,212
2022 $1,251
2021 $1,630
2020 $826
2019 $534
2018 $502
2017 $375
2016 $237
2015 $208
2014 $211
2013 $211
2012 $196
2011 $205
2010 $176
2009 $155
Evotec AG Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,065
2024-06-30 $1,089
2024-03-31 $1,201
2023-09-30 $1,242
2023-06-30 $1,280
2022-12-31 $1,251
2022-09-30 $1,237
2022-06-30 $1,357
2022-03-31 $1,470
2021-12-31 $1,630
2021-09-30 $1,171
2021-06-30 $1,027
2021-03-31 $956
2020-12-31 $826
2020-09-30 $553
2020-06-30 $524
2020-03-31 $540
2019-12-31 $534
2019-09-30 $514
2019-06-30 $494
2019-03-31 $509
2018-12-31 $502
2018-09-30 $454
2018-06-30 $421
2018-03-31 $417
2017-12-31 $375
2017-09-30 $374
2017-06-30 $346
2017-03-31 $334
2016-12-31 $237
2016-09-30 $216
2016-06-30 $211
2016-03-31 $202
2015-12-31 $208
2015-09-30 $197
2015-06-30 $200
2015-03-31 $184
2014-12-31 $211
2014-09-30 $206
2014-06-30 $215
2014-03-31 $214
2013-12-31 $211
2013-09-30 $235
2013-06-30 $192
2013-03-31 $197
2012-12-31 $196
2012-09-30 $198
2012-06-30 $195
2012-03-31 $190
2011-12-31 $205
2011-09-30 $211
2011-06-30 $199
2011-03-31 $178
2010-12-31 $176
2010-09-30 $171
2010-06-30 $152
2010-03-31 $157
2009-12-31 $155
2009-09-30 $172
2009-06-30 $174
2009-03-31 $178
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.513B $0.846B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.364B 28.23
Chugai Pharmaceutical (CHGCY) Japan $72.468B 28.23
Takeda Pharmaceutical (TAK) Japan $42.160B 8.77
Merck (MKKGY) Germany $18.527B 16.59
Sandoz Group AG (SDZNY) Switzerland $17.930B 0.00
Astellas Pharma (ALPMY) Japan $17.409B 16.03
United Therapeutics (UTHR) United States $16.082B 15.82
Neurocrine Biosciences (NBIX) United States $13.958B 36.96
Summit Therapeutics (SMMT) United States $13.532B 0.00
Shionogi (SGIOY) Japan $11.859B 11.88
Madrigal Pharmaceuticals (MDGL) United States $6.844B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.477B 0.00
Corcept Therapeutics (CORT) United States $5.236B 39.66
Crinetics Pharmaceuticals (CRNX) United States $4.781B 0.00
PTC Therapeutics (PTCT) United States $3.539B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.817B 0.00
Dyne Therapeutics (DYN) United States $2.591B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.567B 11.63
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.404B 14.37
NewAmsterdam Pharma (NAMS) Netherlands $2.398B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.307B 0.00
Soleno Therapeutics (SLNO) United States $1.971B 0.00
Indivior (INDV) United States $1.723B 7.02
Xencor (XNCR) United States $1.665B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.622B 0.00
Ocular Therapeutix (OCUL) United States $1.374B 0.00
Harrow (HROW) United States $1.302B 0.00
Guardian Pharmacy Services (GRDN) United States $1.259B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.256B 0.00
Ardelyx (ARDX) United States $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.168B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.060B 0.00
ARS Pharmaceuticals (SPRY) United States $1.041B 0.00
Collegium Pharmaceutical (COLL) United States $0.923B 5.04
Bioventus (BVS) United States $0.863B 27.26
Cronos Group (CRON) Canada $0.788B 0.00
Relay Therapeutics (RLAY) United States $0.720B 0.00
Oruka Therapeutics (ORKA) United States $0.699B 0.00
USANA Health Sciences (USNA) United States $0.694B 12.86
Ironwood Pharmaceuticals (IRWD) United States $0.693B 0.00
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
Tourmaline Bio (TRML) United States $0.529B 0.00
Savara (SVRA) United States $0.527B 0.00
Xeris Biopharma Holdings (XERS) United States $0.516B 0.00
Verve Therapeutics (VERV) United States $0.509B 0.00
Altimmune (ALT) United States $0.506B 0.00
ProKidney (PROK) United States $0.505B 0.00
OmniAb (OABI) United States $0.494B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Siga Technologies (SIGA) United States $0.446B 5.20
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Akebia Therapeutics (AKBA) United States $0.415B 0.00
Korro Bio (KRRO) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.381B 0.00
Jupiter Neurosciences (JUNS) United States $0.347B 0.00
Avita Medical (RCEL) United States $0.335B 0.00
Aquestive Therapeutics (AQST) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.311B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.305B 123.71
4D Molecular Therapeutics (FDMT) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 16.00
Amylyx Pharmaceuticals (AMLX) United States $0.268B 0.00
Larimar Therapeutics (LRMR) United States $0.256B 0.00
Heron Therapeutics (HRTX) United States $0.243B 0.00
Profound Medical (PROF) Canada $0.237B 0.00
Inhibikase Therapeutics (IKT) United States $0.221B 0.00
Lexeo Therapeutics (LXEO) United States $0.221B 0.00
Silence Therapeutics (SLN) United Kingdom $0.215B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Lyell Immunopharma (LYEL) United States $0.188B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Acrivon Therapeutics (ACRV) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
VAXART, INC (VXRT) United States $0.163B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
Metagenomi (MGX) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.137B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Achieve Life Sciences (ACHV) Canada $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.121B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
ElectroCore (ECOR) United States $0.110B 0.00
Inotiv (NOTV) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
Context Therapeutics (CNTX) United States $0.089B 0.00
Century Therapeutics (IPSC) United States $0.088B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Journey Medical (DERM) United States $0.084B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.25
PMV Pharmaceuticals (PMVP) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.069B 0.00
OptiNose (OPTN) United States $0.067B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.067B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
FibroGen (FGEN) United States $0.053B 0.00
Scienture Holdings (SCNX) United States $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
AleAnna (ANNA) United States $0.051B 0.00
Nutriband (NTRB) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.049B 0.00
Surrozen (SRZN) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
BioVie (BIVI) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Traws Pharma (TRAW) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.88